Nanocarrier for the Transdermal Delivery of an Antiparkinsonian Drug

METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES

John H. Draize, Geoffrey E. Woodard, Herbert O. Calvery · Journal of Pharmacology and Experimental Therapeutics · 1944 · 2.6K citations

Pharmacy, Dermatology, Toxicology +8

Encyclopedia of pharmaceutical technology

Choice Reviews Online · 2003 · 1.7K citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutical Biotechnology +12

What contributes to quality of life in patients with Parkinson's disease?

Anette Schrag · Journal of Neurology Neurosurgery & Psychiatry · 2000 · 1.4K citations · Full text

Medicine, Neurology, Movement Disorders +15

Sydney multicenter study of Parkinson's disease: Non‐<scp>L</scp>‐dopa–responsive problems dominate at 15 years

M. A. Hely, John G. Morris, Wayne G.J. Reid et al. · Movement Disorders · 2004 · 1K citations

Medicine, Neurology, Pharmacotherapy +13

Nanoemulsion Components Screening and Selection: a Technical Note

Adnan Azeem, Mohammad Rizwan, Farhan Jalees Ahmad et al. · AAPS PharmSciTech · 2009 · 541 citations · Full text

Pharmacy, Materials Engineering, Materials Science +14